Cancer clinical trials in the region Pays de la Loire
374 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Lymphoma
#NCT06911502
B cell lymphoma
Follicular lymphoma
None
> 60 ml/min
1
2
3 or more
Chemotherapy
Monoclonal antibodies
5 recruiting sites
Celgene
Phase 3
Lung cancer
#NCT05899608
#2024-513087-26-00
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Metastatic
None
Systemic Treatment-Naive
15 recruiting sites
Summit Therapeutics
Phase 3
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
Stomach and esophageal cancer
#NCT07087054
#2024-519875-24-00
Neuroendocrine tumor
None
6 recruiting sites
Crinetics Pharmaceuticals Inc.
Phase 3
Lung cancer
#NCT04613596
#2023-508922-83-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
16 recruiting sites
Mirati Thérapeutique Inc.
Phase 3
Lung cancer
#NCT06908993
#2024-519971-25-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MET
1
2
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
HER2
KRAS non G12C
RET
ROS-1
Systemic Treatment-Naive
Targeted therapy
31 recruiting sites
Intergroupe Francophone de Cancérologie Thoracique
Phase 3
Lymphoma
#NCT05947851
#2022-501560-17-01
B cell lymphoma
Lymphocytic lymphoma
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
Targeted therapy
3 recruiting sites
Merck Sharp & Dohme LLC
Phase 3
CLL & Richter's syndrome
#NCT05947851
#2022-501560-17-01
CLL (Chronic Lymphocytic Leukemia)
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
Targeted therapy
3 recruiting sites
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
#NCT06293625
Adenocarcinoma
Locally Advanced
MSS/pMMR
None
Systemic Treatment-Naive
MSI/dMMR
57 recruiting sites
CHU Dijon
Phase 3
Colon cancer
#NCT06107920
#2024-516456-17-00
Adenocarcinoma
Localized
MSS/pMMR
None
Systemic Treatment-Naive
Chemotherapy
Radiotherapy
3 recruiting sites
CHU Rouen
Phase 3
Colon cancer
#NCT05855200
#2023-503265-27-00
Adenocarcinoma
Localized
Locally Advanced
MSI/dMMR
None
Systemic Treatment-Naive
Systemic Treatment-Naive
MSS/pMMR
9 recruiting sites
GlaxoSmithKline